Mr Derek Davies

Flow Cytometry Section Chair

The Francis Crick Institute

Derek runs a large flow cytometry core facility at Cancer Research UK’s London Research Institute which covers all aspects of cell analysis and sorting. He co-organises the section’s annual flow cytometry course at the University of York and is active in promotion of cytometry via focussed meetings and other courses. He is one of the principal organisers of the flowcytometryUK biennial meeting and also the Advances in Cytometry Meeting. Derek is particularly keen to promote cytometry education within the UK and beyond.

Dr Ian Titley

Flow Cytometry Deputy Chair and Representative infocus Editorial Board

Institute of Cancer Research
Ian gained his PhD at King’s College Hospital, London in 1994. From there he moved to the Institute of Cancer Research at South Kensington to run a research flow cytometry facility and moved in 2007 to do the same for the Institute at its Sutton, Surrey campus. He is a member of the Centre for Evolution and Cancer.

Mr Anthony Carter

Royal Liverpool and Broadgreen University Hospital

Mr Mark Cheetham

Propel Labs
Mark currently looks after the European interests of Propel Labs Inc, a Fort Collins based company developing Flow Cytometry solutions for both individual users and corporate entities. Mark started his Flow Cytometry career in 1984 running a facility at Guy’s Hospital, London. Since then he has worked for Flow Cytometer manufacturers, training and supporting customers as well as launching and marketing new systems. He has been lucky enough to be involved in the development of several successful software, hardware and reagent products. During his career Mark has been very active in the education of both new and advanced Flow Cytometry users. He has participated in many UK and International courses presenting on the principles and applications of Flow Cytometry.

Dr Irene Del Molino Del Barrio

University of Oxford

Irene currently works at the University of Oxford as a postdoctoral researcher investigating Drug Discovery in Friedreich's Ataxia using flow cytometry. Previously she obtained her PhD from Newcastle University, where she used flow cytometry to research the involvement of chemokine receptors in breast cancer. She is particularly interested in educating and promoting flow cytometry to new users.

Dr Helen Ferry

University of Oxford

Helen’s interest in flow cytometry began when she was a DPhil student investigating B cell tolerance in autoimmunity. In 2007 Helen became the flow cytometry facility manager for a haematopoietic stem cell group in the WIMM, Oxford. Three years later, she took up her current position as the manager of the Translational Gastroenterology Unit’s flow cytometry facility, based in the John Radcliffe Hospital. Helen is a member of the Oxford Cytometry Club committee.

Dr Andy Filby

Newcastle University Centre for Life
Dr Filby obtained his PhD from the National Institute for Medical Research (NIMR) in Mill Hill, London where he studied the role of the Src family kinases Lck and Fyn in T cell function.  He is currently head of the Flow Cytometry Core Facilit (FCCF) at Newcastle University leading a dedicated team of flow cytometry specialists with the sole aim of providing a comprehensive, cutting edge cytometry resource to the wider research community at Newcastle University and beyond.  A significant part of his focus is the development of novel cytometry-based techniques that have underpinned several high profile publications in journals including Science and Cell.  He also received the Cytometry Part A paper of the year accolade in 2011.  He specialises in Imaging Flow Cytometry and the use of fluorescence dyes to track cell proliferation.  Dr Filby is also an International Society for the Advancement of Cytometry (ISAC) Shared Resource Laboratory Emerging Leader (SRL-EL) and is heavily involved in a number of educational initiatives for cytometry at both national and international levels.  

Dr Richard Grenfell

Cancer Research UK

After studying Chemistry at Salford University, Richard worked in the oligonucleotide synthesis group at the MRC’s Laboratory of Molecular Biology, before changing direction and running the flow cytometry equipment for the LMB for 8 years.  Moving to Cancer Research UK, Richard runs the Flow Cytometry core facility at the Cancer Research UK, Cambridge Institute, at Cambridge University.  Richard is involved with local, national and international cytometry groups.

Dr Andrew Herman

University of Bristol
Andy is the Director of the Flow Cytometry Facility at the University of Bristol. He trained as an immunologist after receiving a BS in Microbiology at the University of Maryland and a PhD in Microbiology from the University of Virginia. He is involved in teaching and research in his role running a core facility for the users across the university and the wider scientific community.

Dr Karen Hogg

University of York

Dr Gareth Howell

University of Manchester
Gareth is the Flow Cytometry Facility Manager at the Manchester Collaborative Centre for Inflammation Research at the University of Manchester.

Dr Robert Jepras

GlaxoSmithKline

Dr Rob Jepras has worked in and led several research teams in both industry and public health. He has spent over 20 years at GSK in the UK working in both Drug Development and Drug Discovery supporting both product development and drug research. Rob currently works in Drug Discovery Sciences at GSK, leading drug discovery and capability projects and supporting pre- candidate drug discovery. Recent work focuses on using high content multi parametric microscopic technologies for phenotyic screening using human disease relevant systems, and the develpoment of microscale technologies (microfluidics/nanowells) to enhance drug discovery efforts.

Mrs Niga Nawroly

ACEA Biosciences
Niga is a qualified immunologist from Imperial College London with 10 years’ experience of the management of a successful flow cytometry facility. She has also worked for a number of flow cytometry reagents and instrumentation companies.  She is interested in education in flow cytometry either as an organiser or a teacher/trainer.   She has been an active member of the Flow Cytometry Committee for a number of years. 

Mr Dan Payne

Leicester Royal Infirmary
Dan is the Principal Clinical Scientist for the Leicester Royal Infirmary Clinical Immunophenotyping Service and Clinical Lead for flow cytometry in empath pathology; a service covering Leicestershire and Nottinghamshire hospitals. The empath flow cytometry services form part of a comprehensive Immunology and Haemato-Oncology service for integrated diagnostics. Dan is a member of the MIG UK group and the UK PNH Diagnostic interest group. He has participated in advisory boards and as a lecturer in a number of courses within the UK and Europe.

Dr Rebecca Pike

Queen Mary University of London

Becki studied Pharmacology at Cardiff University before completing her PhD in Immunology and Molecular Pathology at the MRC National Institute for Medical Research. After working in a flow cytometry role at UCL, she has managed the flow cytometry facility for Bart’s Cancer Institute and the William Harvey Research Institute at Queen Mary University of London for the past 3 years, working with both flow cytometry and mass cytometry. Becki is also a member of the London Cytometry Club committee.

Dr Rachael Walker

Babraham Institute
Rachael is the Head of Flow Cytometry Core Facility at Babraham Institute, Cambridge. The core provides a service to Babraham Institute and biotech companies that are housed on the Babraham Research Campus. She is also very involved with the flow cytometry community, on a local, national and International level. Rachael is one of the principle organisers of the flowcytometryUK biennial meeting and also the Advances in Cytometry meeting.
Rachael has been awarded an ‘Emerging Leader ‘ scholarship from the International Society for the Advancement of Cytometry (ISAC).

Dr Fredrik Wallberg DipRMS

Institute of Cancer Research

Fredrik runs the flow Cytometry Facility at the Chelsea campus of Institute of Cancer Research. He has been the manager since 2006. He is also involved in time lapse microscopy, confocal microscopy and high content microscopy. Before he joined the Institute of cancer research he worked both in Sweden and the Netherlands with flow Cytometry. He has succesfully completed the RMS Diploma in which his project focussed on cell death and time lapse microscopy.